GoldenGolden
Advanced Search
Alpha Tau Medical

Alpha Tau Medical

Alpha Tau Medical provides highly potent and conformal Alpha Radiotherapy (Alpha DaRT) for solid cancer tumors.

Help us improve this page by adding information.
Visit our Writing Guide or this topic page for additional help.

Timeline

July 8, 2021
Alpha Tau hops aboard the SPAC train with $367M deal to take its tumor-blasting tech public.
June 8, 2021
Alpha Tau Medical receives a Breakthrough Device Designation for Alpha DaRT from the FDA.
June 4, 2020
Alpha Tau Medical raises a $26,000,000 series B round.
June 4, 2020
Alpha Tau Medical raises a $26,000,000 series B round from Shavit Capital.

Funding rounds

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Andrea Park
July 8, 2021
FierceBiotech
Armed with a recent vote of confidence from the FDA for its tumor-destroying radiation technology, Alpha Tau Medical is plowing ahead with plans to go public before the end of the year.
Alpha Tau Medical
June 8, 2021
www.prnewswire.com:443
/PRNewswire/ -- Alpha Tau Medical, the developer of the pioneering alpha-radiation cancer therapy Alpha DaRT,TM is pleased to announce that it has received a...
FinSMEs
June 4, 2020
FinSMEs
About | Advertise | Contact | Disclaimer | News | The Daily Deal Newsletter FinSMEs.com by FinSMEs is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.